American Heart Month

Extensive research is trying to identify strategies to promote heart health and avoid the related risk factors for cardiovascular disease (CVD). Of particular interest is the role of folate and homocysteine (Hcy), causally related to Coronary Artery Disease (CAD) and stroke, as reported by many observational studies.
Folate is an important regulator of Hcy metabolism and helps to maintain normal plasma homocysteine concentrations. An increase in homocysteine is associated with low levels of vitamin B6, B12, and folate. Hence, vitamin supplementation with vitamins B6, B12, and folate may reduce the risk of compromised heart health by lowering Hcy levels, as clinical studies report.
Quatrefolic® has been tested (in conjunction with our partners) for cardiovascular impact, including the normalization of Hcy.
Discover in the specific cardiovascular brochure the study results and tangible advantages of Quatrefolic® versus folic acid to support healthier heart life.